Canopus BioPharma Incorporated
Save
836.32K
Market cap
–
Current P/E
–
Forward P/E
About
Financial Services
Sector
Shell Companies
Industry
Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals. The company was founded in 1996 as Canopus Corporation and changed its name in 2007.
Similar securities
Based on sector and market capitalization
Report issue